Neuland Laboratories posts blockbuster FY26 performance

Suven Life Sciences reaches 76% milestone in Phase 3 masupirdine trial for Alzheimer’s agitation

The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies

Dr. Reddy’s to participate in HSBC, Bank of America investor conferences

Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026

Plus Therapeutics subsidiary clears key Medicare milestone

Paves way for CNS cancer test rollout

CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge

The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market

Bike rally in Hyderabad promotes thalassemia awareness

75 bikers participated in the rally organised by Thalassemia and Sickle Cell Society to promote early screening and voluntary blood donation

JB Chemicals reports muted Q4 FY26 as integration resets business

The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year

SwishX raises $2.2 million seed to launch agentic AI for pharma and MedTech

Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents

Over 3,500 participate in NHA's AI hackathon

Initiative by National Health Authority aimed at accelerating automated claims processing under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana

From lab bench to market: Strengthening translational research in India’s biotech ecosystem

India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells